Skip to main content

Cardinal Health(CAH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low216.43
Day High222.62
Open:221.13
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Cardinal Health

Select a category then submit the form to load news
StockStory
2 S&P 500 Stocks with Solid Fundamentals and 1 We Turn Down
TXN
Tipranks
Cardinal Health Announces Planned Chief Accounting Officer Transition
StockStory
Q4 Earnings Roundup: Cardinal Health (NYSE:CAH) And The Rest Of The Healthcare Providers & Services Segment
CAH
Zacks Investment Research
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
StockStory
1 Profitable Stock to Keep an Eye On and 2 We Avoid
CSX
Zacks Investment Research
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Zacks Investment Research
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y
Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y
Zacks Investment Research
TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market
TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market
Tipranks
Wall Street Analysts Are Neutral on Top Healthcare Picks
Tipranks
Barclays Sticks to Its Buy Rating for Cardinal Health (CAH)
Zacks Investment Research
Bull of the Day: Cardinal Health (CAH)
Bull of the Day: Cardinal Health (CAH)
Motley Fool
Beck Bode Initiates Churchill Downs Position as Regional Gaming Expansion Lifts Growth Prospects
Zacks Investment Research
Zacks Investment Ideas feature highlights Cardinal Health and Palantir
Zacks Investment Ideas feature highlights Cardinal Health and Palantir
Zacks Investment Research
Q4 Earnings: These Buy-Rated Stocks Crushed Expectations
Q4 Earnings: These Buy-Rated Stocks Crushed Expectations
Zacks Investment Research
Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up
Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up
Zacks Investment Research
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market
Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market
Zacks Investment Research
MDT Stock Up on Q3 Earnings and Revenue Beat, Margins Down
MDT Stock Up on Q3 Earnings and Revenue Beat, Margins Down
Zacks Investment Research
Best Momentum Stock to Buy for February 13th
Best Momentum Stock to Buy for February 13th
Zacks Investment Research
BAX Stock Falls Following Q4 Earnings Miss, Margins Contract
BAX Stock Falls Following Q4 Earnings Miss, Margins Contract
StockStory
The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call
CAH
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Biogen (BIIB) and Quest Diagnostics (DGX)
Tipranks
Cardinal Health price target raised to $255 from $245 at Morgan Stanley
Tipranks
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Cardinal Health (CAH)
Tipranks
Barclays Remains a Buy on Cardinal Health (CAH)
Tipranks
Cardinal Health’s Earnings Call Highlights Broad-Based Upswing
Tipranks
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Cardinal Health (CAH)
Tipranks
Cardinal Health posts strong Q2 results, raises guidance
StockStory
CAH Q4 Deep Dive: Specialty and Growth Segments Drive Outperformance and Upgraded Outlook
CAH
StockStory
Why Is Cardinal Health (CAH) Stock Rocketing Higher Today
CAH
Motley Fool
Cardinal Health (CAH) Q2 2026 Earnings Transcript
StockStory
Cardinal Health (NYSE:CAH) Exceeds Q4 CY2025 Expectations
CAH
Motley Fool
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio

Profile

Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.'

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.